Clinical Trials Logo

Clinical Trial Summary

This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.


Clinical Trial Description

PRIMARY OBJECTIVES: I. Evaluate feasibility of the electronic batteries, measured by the completion rate and time to completion of the batteries. SECONDARY OBJECTIVES: I. Comparison of the completion rate and time to completion between the written and electronic batteries. II. Comparison of the scoring distribution between the screening tools. EXPLORATORY OBJECTIVES: I. Assess if a history of mental or cognitive illness or ongoing treatment with neuropsychiatric medications impact the ability to complete written and/or electronic neurocognitive screening. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen cognitive assessment within 2 months prior to surgery and within 2 months after surgery. GROUP II: Patients receive the paper and pen cognitive assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03678441
Study type Interventional
Source M.D. Anderson Cancer Center
Contact
Status Active, not recruiting
Phase N/A
Start date August 17, 2018
Completion date April 30, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT03214510 - Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery Phase 3
Active, not recruiting NCT02156739 - Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions N/A
Recruiting NCT05876182 - Vancomycin in Primary Sclerosing Cholangitis in Italy Phase 2